Sole Financial Adviser
Kempen & Co Deal Alert | Sole Financial Adviser in the sale of Sanquin Reagents by Sanquin Health Solutions to Gilde Healthcare
Sanquin Reagents is part of Sanquin Health Solutions and has been an active player in the field of laboratory diagnostics by developing, producing and supplying both conventional and innovative products for diagnostics for more than 40 years. Sanquin Reagents develops and produces reagents for blood grouping and specific plasma proteins (IgG subclasses, cytokines, CD monoclonals). These reagents are for in vitro diagnostic use or for research use only and with these products, Sanquin Reagents aims to enhance the health of people.
It is the mission of Sanquin Health Solutions to fully unlock and utilize the potential of blood and science for the benefit of patients. SHS is the parent company of Sanquin's private activities in the fields of diagnostics, in vitro reagents, technology innovation and science campus development. SHS also has a number of participating interests. SHS is 100% owned by the Sanquin Blood Supply Foundation. Proceeds from SHS's commercial activities benefit, among other things, its research activities, which are used to develop new drugs and treatment methods.
In the last twelve months, Kempen & Co has successfully completed a large number of transactions in its Life Sciences & Healthcare franchise. Recent transactions include: